Clinical Trial Update: Pre-Surgical Sutent in Renal Cell Carcinoma (RCC) [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial of pre-surgical sunitinib (Sutent) for renal cell carcinoma. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Renal Cell Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING